Michael Chong1,2,3, Pedrum Mohammadi-Shemirani2,3,4, Nicolas Perrot3, Walter Nelson5, Robert Morton2,3, Sukrit Narula3,6, Ricky Lali3,6, Irfan Khan2,3, Mohammad Khan3,7, Conor Judge3,8, Tafadzwa Machipisa2,3,9,10, Nathan Cawte3, Martin O'Donnell3,8, Marie Pigeyre3,7, Loubna Akhabir3,7, Guillaume Paré1,2,3,6,7. 1. Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada. 2. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada. 3. Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton Health Sciences, Hamilton, Canada. 4. Thrombosis and Atherosclerosis Research Institute, Hamilton, Canada. 5. Centre for Data Science and Digital Health, Hamilton Health Sciences, Hamilton, Canada. 6. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada. 7. Department of Medicine, McMaster University, Michael G. DeGroote School of Medicine, Hamilton, Canada. 8. National University of Ireland, Galway, Galway, Ireland. 9. Department of Medicine, University of Cape Town & Groote Schuur Hospital, Cape Town, South Africa. 10. Hatter Institute for Cardiovascular Diseases Research in Africa (HICRA) & Cape Heart Institute (CHI), Department of Medicine, University of Cape Town, Cape Town, South Africa.
Abstract
Background: Mitochondrial DNA copy number (mtDNA-CN) is an accessible blood-based measurement believed to capture underlying mitochondrial (MT) function. The specific biological processes underpinning its regulation, and whether those processes are causative for disease, is an area of active investigation. Methods: We developed a novel method for array-based mtDNA-CN estimation suitable for biobank-scale studies, called 'automatic mitochondrial copy (AutoMitoC).' We applied AutoMitoC to 395,781 UKBiobank study participants and performed genome- and exome-wide association studies, identifying novel common and rare genetic determinants. Finally, we performed two-sample Mendelian randomization to assess whether genetically low mtDNA-CN influenced select MT phenotypes. Results: Overall, genetic analyses identified 71 loci for mtDNA-CN, which implicated several genes involved in rare mtDNA depletion disorders, deoxynucleoside triphosphate (dNTP) metabolism, and the MT central dogma. Rare variant analysis identified SAMHD1 mutation carriers as having higher mtDNA-CN (beta = 0.23 SDs; 95% CI, 0.18-0.29; p=2.6 × 10-19), a potential therapeutic target for patients with mtDNA depletion disorders, but at increased risk of breast cancer (OR = 1.91; 95% CI, 1.52-2.40; p=2.7 × 10-8). Finally, Mendelian randomization analyses suggest a causal effect of low mtDNA-CN on dementia risk (OR = 1.94 per 1 SD decrease in mtDNA-CN; 95% CI, 1.55-2.32; p=7.5 × 10-4). Conclusions: Altogether, our genetic findings indicate that mtDNA-CN is a complex biomarker reflecting specific MT processes related to mtDNA regulation, and that these processes are causally related to human diseases. Funding: No funds supported this specific investigation. Awards and positions supporting authors include: Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (MC, PM); CIHR Post-Doctoral Fellowship Award (RM); Wellcome Trust Grant number: 099313/B/12/A; Crasnow Travel Scholarship; Bongani Mayosi UCT-PHRI Scholarship 2019/2020 (TM); Wellcome Trust Health Research Board Irish Clinical Academic Training (ICAT) Programme Grant Number: 203930/B/16/Z (CJ); European Research Council COSIP Grant Number: 640580 (MO); E.J. Moran Campbell Internal Career Research Award (MP); CISCO Professorship in Integrated Health Systems and Canada Research Chair in Genetic and Molecular Epidemiology (GP).
Background: Mitochondrial DNA copy number (mtDNA-CN) is an accessible blood-based measurement believed to capture underlying mitochondrial (MT) function. The specific biological processes underpinning its regulation, and whether those processes are causative for disease, is an area of active investigation. Methods: We developed a novel method for array-based mtDNA-CN estimation suitable for biobank-scale studies, called 'automatic mitochondrial copy (AutoMitoC).' We applied AutoMitoC to 395,781 UKBiobank study participants and performed genome- and exome-wide association studies, identifying novel common and rare genetic determinants. Finally, we performed two-sample Mendelian randomization to assess whether genetically low mtDNA-CN influenced select MT phenotypes. Results: Overall, genetic analyses identified 71 loci for mtDNA-CN, which implicated several genes involved in rare mtDNA depletion disorders, deoxynucleoside triphosphate (dNTP) metabolism, and the MT central dogma. Rare variant analysis identified SAMHD1 mutation carriers as having higher mtDNA-CN (beta = 0.23 SDs; 95% CI, 0.18-0.29; p=2.6 × 10-19), a potential therapeutic target for patients with mtDNA depletion disorders, but at increased risk of breast cancer (OR = 1.91; 95% CI, 1.52-2.40; p=2.7 × 10-8). Finally, Mendelian randomization analyses suggest a causal effect of low mtDNA-CN on dementia risk (OR = 1.94 per 1 SD decrease in mtDNA-CN; 95% CI, 1.55-2.32; p=7.5 × 10-4). Conclusions: Altogether, our genetic findings indicate that mtDNA-CN is a complex biomarker reflecting specific MT processes related to mtDNA regulation, and that these processes are causally related to human diseases. Funding: No funds supported this specific investigation. Awards and positions supporting authors include: Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (MC, PM); CIHR Post-Doctoral Fellowship Award (RM); Wellcome Trust Grant number: 099313/B/12/A; Crasnow Travel Scholarship; Bongani Mayosi UCT-PHRI Scholarship 2019/2020 (TM); Wellcome Trust Health Research Board Irish Clinical Academic Training (ICAT) Programme Grant Number: 203930/B/16/Z (CJ); European Research Council COSIP Grant Number: 640580 (MO); E.J. Moran Campbell Internal Career Research Award (MP); CISCO Professorship in Integrated Health Systems and Canada Research Chair in Genetic and Molecular Epidemiology (GP).
Authors: Christopher Kim; Bryan A Bassig; Wei Jie Seow; Wei Hu; Mark P Purdue; Wen-Yi Huang; Chin-San Liu; Wen-Ling Cheng; Satu Männistö; Roel Vermeulen; Stephanie J Weinstein; Unhee Lim; H Dean Hosgood; Matthew R Bonner; Neil E Caporaso; Demetrius Albanes; Qing Lan; Nathaniel Rothman Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-10-07 Impact factor: 4.254
Authors: Lena F Burbulla; Pingping Song; Joseph R Mazzulli; Enrico Zampese; Yvette C Wong; Sohee Jeon; David P Santos; Judith Blanz; Carolin D Obermaier; Chelsee Strojny; Jeffrey N Savas; Evangelos Kiskinis; Xiaoxi Zhuang; Rejko Krüger; D James Surmeier; Dimitri Krainc Journal: Science Date: 2017-09-07 Impact factor: 47.728
Authors: Domenico Simone; Francesco Maria Calabrese; Martin Lang; Giuseppe Gasparre; Marcella Attimonelli Journal: BMC Genomics Date: 2011-10-20 Impact factor: 3.969
Authors: Danielle A Sliter; Jennifer Martinez; Ling Hao; Xi Chen; Nuo Sun; Tara D Fischer; Jonathon L Burman; Yan Li; Zhe Zhang; Derek P Narendra; Huaibin Cai; Max Borsche; Christine Klein; Richard J Youle Journal: Nature Date: 2018-08-22 Impact factor: 49.962
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Christian Benner; Chris C A Spencer; Aki S Havulinna; Veikko Salomaa; Samuli Ripatti; Matti Pirinen Journal: Bioinformatics Date: 2016-01-14 Impact factor: 6.937
Authors: Gloria T Haskell; Mari Mori; Cynthia Powell; Timothy J Amrhein; Gillian I Rice; Lauren Bailey; Natasha Strande; Karen E Weck; James P Evans; Jonathan S Berg; Priya Kishnani Journal: Cold Spring Harb Mol Case Stud Date: 2018-10-01
Authors: Anna L Guyatt; Rebecca R Brennan; Kimberley Burrows; Philip A I Guthrie; Raimondo Ascione; Susan M Ring; Tom R Gaunt; Angela Pyle; Heather J Cordell; Debbie A Lawlor; Patrick F Chinnery; Gavin Hudson; Santiago Rodriguez Journal: Hum Genomics Date: 2019-01-31 Impact factor: 4.639
Authors: Pauli Virtanen; Ralf Gommers; Travis E Oliphant; Matt Haberland; Tyler Reddy; David Cournapeau; Evgeni Burovski; Pearu Peterson; Warren Weckesser; Jonathan Bright; Stéfan J van der Walt; Matthew Brett; Joshua Wilson; K Jarrod Millman; Nikolay Mayorov; Andrew R J Nelson; Eric Jones; Robert Kern; Eric Larson; C J Carey; İlhan Polat; Yu Feng; Eric W Moore; Jake VanderPlas; Denis Laxalde; Josef Perktold; Robert Cimrman; Ian Henriksen; E A Quintero; Charles R Harris; Anne M Archibald; Antônio H Ribeiro; Fabian Pedregosa; Paul van Mulbregt Journal: Nat Methods Date: 2020-02-03 Impact factor: 28.547